Vaxjo Home

Introduction

Statistics

News and Updates

Vaxjo Query

Selected Adjuvants

adamantylamide dipeptide vaccine adjuvant

aluminum hydroxide vaccine adjuvant

alhydrogel vaccine adjuvant

Data Submission

Data Exchange

Data Download

Documentation

FAQs

Disclaimer

Contact Us

Vaxjo: Vaccine Adjuvants

Currently, Vaxjo includes 389 vaccine adjuvants. The detailed curated data is shown below:

Index	Vaccine Adjuvant Name	No. of associated vaccines	VO ID
1	1P7	0	VO_0005540
2	1V270	1	VO_0005270
3	2B182C	0	VO_0005271
4	2E151	0	VO_0005281
5	2F52	1	VO_0005303
6	2G023A	0	VO_0006097
7	2GO53	0	VO_0005777
8	3DSNA	0	VO_0005684
9	3M-052-AF	0	VO_0005474
10	3M-052-Alum	0	VO_0005387
11	3M-052-SE	0	VO_0005386
12	3pRNA	1	VO_0005270
13	7DW8-5	0	VO_0005780
14	A-910823	0	VO_0006103
15	AAHS	0	VO_0005715
16	AAV-IL-27	0	VO_0005721
17	Abisco-100 vaccine adjuvant	1	VO_0001334
18	ACM-CPG	0	VO_0006106
19	Ad-p53	0	VO_0005520
20	Ad-SLC	0
21	Adamantylamide Dipeptide Vaccine Adjuvant	1	VO_0000559
22	Adjumer	1	VO_0000351
23	Adjuplex+GLA	0	VO_0005302
24	ADP-ribosylating adjuvant	0	VO_0005764
25	Advax	1	VO_0005207
26	Advax-CpG55.2	0	VO_0005324
27	AF03	1	VO_0001330
28	AH:CpG	0	VO_0005730
29	Aikejia	0	VO_0005686
30	Alarmin IL-33	1	VO_0005270
31	Albumin-heparin microparticles vaccine adjuvant	0	VO_0001335
32	ALF	1	VO_0005270
33	ALFQ	0	VO_0006096
34	Algal Glucan	0	VO_0001285
35	Algammulin	1	VO_0001286
36	Algel-IMDQ	0	VO_0005722
37	Alhydrogel	13	VO_0001241
38	Alhydroxiquim-II	1	VO_0005301
39	AlO(OH)-polymer nanoparticles	1	VO_0005270
40	AlT3	0	VO_0005300
41	AlT4	0	VO_0005299
42	Alum and IL-10	0
43	Alum-TLR7	0
44	aluminum hydroxide vaccine adjuvant	63	VO_0000127
45	aluminum phosphate vaccine adjuvant	49	VO_0000128
46	aluminum potassium sulfate adjuvant	6	VO_0001240
47	Aluminum vaccine adjuvant	14	VO_0000884
48	amorphous aluminum hydroxyphosphate sulfate adjuvant	2	VO_0001323
49	AmpB	0	VO_0005673
50	AP adjuvant	0	VO_0005744
51	APS	0	VO_0005581
52	Arlacel A	1	VO_0000191
53	AS-2 vaccine adjuvant	1	VO_0001336
54	AS01	0
55	AS02	4	VO_0001264
56	AS03	2	VO_0001320
57	AS04	1	VO_0001265
58	AS15	0	VO_0005672
59	Avridine®	1	VO_0001288
60	B7-2 vaccine adjuvant	1	VO_0001337
61	Babassu aqueous extract	0	VO_0005555
62	Bay R1005	1	VO_0001287
63	BECC438b	0	VO_0005298
64	BECC438s	0	VO_0005297
65	BECC470b	0	VO_0005296
66	BECC470s	0	VO_0005383
67	BI-Eng2	0	VO_0005507
68	BI-Eng2+Adjuplex	0	VO_0005508
69	Bordetella pertussis component Vaccine Adjuvant	3	VO_0000193
70	Bupivacaine vaccine adjuvant	0	VO_0001338
71	c-di-AMP	0	VO_0005680
72	C3 adjuvant	0	VO_0005536
73	C60(OH)22	0	VO_0005678
74	CA-CpG	1	VO_0005270
75	CAF-01	0	VO_0005483
76	CAF-09	0	VO_0005473
77	CAF04	0	VO_0005659
78	CAF05	0	VO_0005576
79	CAF06	0	VO_0005550
80	CAF23	0	VO_0005675
81	CAF24a	1	VO_0005270
82	Calcium Phosphate Gel	0	VO_0001289
83	Calcium phosphate vaccine adjuvant	1	VO_0000131
84	Candida skin test reagent	0	VO_0005593
85	CaPNP (CaPtivant)(TM)	0	VO_0005295
86	caspase-1	0	VO_0005759
87	Cationic adjuvant formulations (CAFs)	0	VO_0005681
88	Cationic Liposomal Vaccine Adjuvant	2	VO_0001262
89	Cationic liposome-DNA complex JVRS-100	1	VO_0001339
90	CBP-12	0	VO_0005732
91	CCL19	0	VO_0005582
92	CCL21 and IL1β	0	VO_0005771
93	CCL5 adjuvant	0	VO_0005543
94	CD226	1	VO_0005270
95	CDG	1	VO_0005270
96	CGAMP	0	VO_0005591
97	Chitosan	0	VO_0005752
98	Cholera toxin	17	VO_0000143
99	Cholera toxin B subunit	6	VO_0001242
100	CITCO	0	VO_0005720
101	CL429	0	VO_0005671
102	CnB	0	VO_0005560
103	Corynebacterium-derived P40 Vaccine Adjuvant	1	VO_0000146
104	CoVaccine HTâ„¢	0	VO_0005725
105	Cowpea Mosaic Virus	0	VO_0006107
106	CPDI-01	0	VO_0005330
107	CPDI-02	0	VO_0006093
108	CPG 7909	0	VO_0005772
109	CpG andDcMNPs	0
110	CpG DNA Vaccine Adjuvant	15	VO_0001237
111	CpG M362	0	VO_0005753
112	CpG oligodeoxynucleotide 1826	1	VO_0005270
113	CpG-ODN and Coa-ASC16	0	VO_0005667
114	CpG-ODN Shapes Alum Adjuvant	0
115	CRL1005	2	VO_0001318
116	Cry proteins	1	VO_0005270
117	CS3 adjuvant	0	VO_0005534
118	CTA	1	VO_0005270
119	CTA1-DD gene fusion protein	2	VO_0001290
120	CTA2B	0	VO_0005781
121	CTB	1	VO_0005270
122	curcumin	0	VO_0005737
123	CVC1302	0	VO_0005748
124	CXCL10	0
125	CXCL11-Fc	0	VO_0005590
126	CXCL9	0	VO_0005589
127	CyPA	1	VO_0005270
128	D-mannose	1	VO_0005270
129	D-Murapalmitine	0	VO_0001305
130	DAI	0	VO_0005554
131	DDA Adjuvant	3	VO_0001261
132	DDO (Defective derived oligonucleotide)	1	VO_0005294
133	delta-inulin	0	VO_0005723
134	DHEA vaccine adjuvant	1	VO_0001340
135	DL-PGL (Polyester poly (DL-lactide-co-glycolide)) vaccine adjuvant	1	VO_0001341
136	DLinDMA	0	VO_0005728
137	dmLT (double mutant of heat-labile E.coli)	0	VO_0005329
138	DOC/Alum Complex	1	VO_0001291
139	DOTAP and DP7-C liposomes	0	VO_0005716
140	E. coli heat-labile toxin, LT	3	VO_0001322
141	EGCG	0	VO_0005749
142	Em	0	VO_0005293
143	EmT4	0	VO_0005292
144	epigallocatechin-3-gallate	0	VO_0005586
145	Etx B subunit Adjuvant	2	VO_0001272
146	Evax-B	0	VO_0005510
147	Evax-S	0	VO_0005511
148	FLAB-PSPA	1	VO_0005270
149	Flagellin	1	VO_0001331
150	FLIC	0	VO_0005575
151	Flt-3 ligand	0	VO_0005535
152	Fos47	0	VO_0005291
153	Freund's Complete Adjuvant	45	VO_0000139
154	Freund's Incomplete Adjuvant	46	VO_0000142
155	Fuc-Sc	0	VO_0005735
156	G2	1	VO_0005270
157	G3	0	VO_0005666
158	Gamma Inulin	1	VO_0001292
159	GC@ICG nanoparticle	0	VO_0005767
160	Gel-gffy	0	VO_0005765
161	Gerbu Adjuvant	1	VO_0001293
162	GITRL	1	VO_0005270
163	GLA-3M-052-LS	0	VO_0005385
164	GLA-AF	0	VO_0005424
165	GLA-Alum	0	VO_0006099
166	GLA-LSQ	0	VO_0005421
167	GLA-SE	0	VO_0005420
168	glycated chitosan	1	VO_0005270
169	GM-CSF	27	VO_0001294
170	GM3	0	VO_0005760
171	GMDP	1	VO_0001295
172	gp63	0	VO_0005537
173	GPI-CCL28	0
174	Granules of mast cells	0	VO_0005579
175	Granulysin	0	VO_0005551
176	Graphene oxide	0	VO_0005585
177	HBcAg	1	VO_0005270
178	HBHA	0	VO_0005558
179	HBsAg	0	VO_0005779
180	hexosomes	0	VO_0005658
181	HIV-1 protease	0	VO_0005546
182	HMBA	0
183	HMGB1	0	VO_0005574
184	IBL027	0
185	IFN-α	0	VO_0005573
186	IFNβ	0	VO_0005740
187	IL-12 Vaccine Adjuvant	14	VO_0001147
188	IL-12-MOP	0	VO_0005509
189	IL-15 vaccine adjuvant	1	VO_0001342
190	IL-1R1	0	VO_0005758
191	IL-21	0	VO_0005738
192	IL-27	0	VO_0005766
193	IL-36	0	VO_0005580
194	IL-7-Fc	0	VO_0005541
195	IL15	1	VO_0005270
196	Imiquimod	1	VO_0001328
197	Immunoliposomes Containing Antibodies to Costimulatory Molecules	1	VO_0001343
198	IMP321	1	VO_0005270
199	INI-2002	0	VO_0005290
200	INI-2004	0	VO_0005289
201	INI-4001	0	VO_0005288
202	Injectable Excipients	0	VO_0005679
203	Interleukin-1β	1	VO_0001297
204	Interleukin-2	1	VO_0001298
205	Interleukin-7	1	VO_0001299
206	IPMPs	1	VO_0005270
207	iron oxide nanoparticles	1	VO_0005270
208	IRX-2	0	VO_0005549
209	ISCOM(s)â„¢	2	VO_0000757
210	ISCOMATRIX®	1	VO_0001333
211	ISG15	0	VO_0005719
212	α-galactosylceramide	0	VO_0005757
213	α-GalCer and MPL	1	VO_0005270
214	K3-SPG	1	VO_0005270
215	Killed Corynebacterium parvum Vaccine Adjuvant	2	VO_0001259
216	KML-B	1	VO_0005270
217	Kynurenine	0	VO_0005733
218	L-NAME	0	VO_0005559
219	L-siRNA	0	VO_0005683
220	L. polysaccharide	0	VO_0005769
221	LAG-3	0
222	LCP	0	VO_0005774
223	LIGHT	1	VO_0005270
224	Lipopolysaccharide Vaccine Adjuvant	1	VO_0000181
225	Liposomes	2	VO_0000366
226	Listeriolysin O	0	VO_0005687
227	LiT4	0	VO_0005287
228	LMQ	0	VO_0006092
229	Loxoribine	1	VO_0001300
230	LP-GMP	0	VO_0005662
231	LQ	0	VO_0005390
232	LT(R192G)	0	VO_0005528
233	LT-IIb	0	VO_0005775
234	LTA1	0	VO_0005355
235	LTK63 Vaccine Mutant Adjuvant	2	VO_0001251
236	LTR192G Vaccine Adjuvant	6	VO_0001321
237	LTR72 vaccine adjuvant	1	VO_0001344
238	Man-TLR7	0	VO_0005743
239	Mannadjuvant	0	VO_0005286
240	MAS-1	0	VO_0005471
241	Mast Cell Activator Small Muscles	0	VO_0005381
242	Mastoparan 7	0	VO_0005380
243	Matrix-S	1	VO_0001324
244	MCP-3	0	VO_0005526
245	MDA5	0	VO_0005583
246	MDP-1	0	VO_0005547
247	Melatonin	0	VO_0005538
248	mesoporous silica nanoparticle	1	VO_0005270
249	MF59	5	VO_0001301
250	MicroCyrstalline Tyrosine® (MCT)	0	VO_0005419
251	MiT4	0	VO_0005285
252	MMG-1	0	VO_0005657
253	monomeric annexin A2	1	VO_0005270
254	Montanide Incomplete Seppic Adjuvant	1	VO_0001269
255	Montanide ISA 51	2	VO_0001270
256	Montanide ISA 720 Adjuvant	6	VO_0001268
257	MPL	0
258	MPL-SE vaccine adjuvant	2	VO_0001345
259	MPLâ„¢ Adjuvant	9	VO_0001250
260	MSP-102	0	VO_0005778
261	MTP-PE Liposomes	2	VO_0001302
262	Murametide	0	VO_0001303
263	Muramyl Dipeptide Adjuvant	1	VO_0000187
264	Murapalmitine	0	VO_0001304
265	Myd88	1	VO_0005270
266	MyD88/CD40	0
267	NAGO	1	VO_0001306
268	Naltrexone	1	VO_0005270
269	NanoAlum	0	VO_0005475
270	nanoemulsion vaccine adjuvant	3	VO_0001319
271	Nanostructured Lipid Carrier (NLC)	0	VO_0005476
272	NanoVax/NE01	0	VO_0005284
273	Nexavant	0	VO_0006108
274	Non-Ionic Surfactant Vesicles	1	VO_0001307
275	non-toxic mutant E112K of Cholera Toxin mCT-E112K	1	VO_0001347
276	NP DNA adjuvant	0	VO_0005542
277	NP-R@M-M	0	VO_0005655
278	NS-TLR	0	VO_0005685
279	OK-432	0	VO_0005668
280	Ophiopogonin D	0	VO_0005660
281	OVA-csNLCs	0	VO_0005736
282	P2Et	1	VO_0005270
283	PAA:nanoalum	0	VO_0005676
284	PAMK	0	VO_0005663
285	PAPE	0	VO_0005717
286	pcIFN-gamma	0	VO_0005527
287	PCL and chitosan NPs	0
288	PEI-PPAS	0	VO_0005763
289	PET Lipid A	0	VO_0005773
290	PhotothermalPhage	0	VO_0005739
291	PI-RI	0	VO_0005782
292	PI-sRI	0	VO_0005776
293	PIKA	0	VO_0005379
294	Pinaceae-derived nanoemulsions	0	VO_0005689
295	PLA-b-P(NAS-co-NVP)	0	VO_0005755
296	Platycodin D	0	VO_0005754
297	PLGA	1	VO_0005270
298	PMMA	1	VO_0001308
299	Poly(I:C)	1	VO_0001332
300	Poly-ϵ-caprolactone and chitosan nanoparticles	0
301	Polyethyleneimine	0	VO_0005768
302	Polygen Vaccine Adjuvant	1	VO_0001273
303	PolyIC:LC	0	VO_0005726
304	Polyinosinic-polycytidylic acid	0	VO_0005661
305	polysorbitol-co-PEI polymer	0	VO_0005727
306	porous silicon microparticle	1	VO_0005270
307	Precision Vaccines Program (PVP)-037	0	VO_0005382
308	Precision Vaccines Program (PVP)-057	0	VO_0006105
309	Pro-LNG-S	0	VO_0005472
310	Propionibacterium acnes(P. acnes)	1	VO_0005270
311	Protein Cochleates	1	VO_0001309
312	PRR agonists	0	VO_0005669
313	pSPreS2	0	VO_0005578
314	QS-17 and18	0	VO_0005677
315	QS-21	1	VO_0001310
316	Quil-A vaccine adjuvant	6	VO_0001263
317	RALDH2	0
318	RC529 vaccine adjuvant	1	VO_0001239
319	rcIL-15	0	VO_0005731
320	Recombinant hIFN-gamma/Interferon-g	1	VO_0001296
321	Rehydragel HPA	1	VO_0001311
322	Rehydragel LV	1	VO_0001312
323	Resiquimod	0	VO_0001329
324	retinoic acid and IL-15	0	VO_0005557
325	rhIL-7 adjuvant	0	VO_0005532
326	Ribi Vaccine Adjuvant	11	VO_0001238
327	RNadjuvant	0
328	rNDV-mOX40L	0	VO_0005741
329	Rotavirus VP6	0	VO_0005682
330	rOv-ASP-1	0	VO_0005327
331	Rv3628	0	VO_0005745
332	S-540956	0	VO_0006104
333	SAF-1	1	VO_0001349
334	SAG1 and TLR-5 ligand	0	VO_0005690
335	saponin and MPLA nanoparticles	0	VO_0005747
336	Saponin Monophosphoryl Lipid-A Nanoparticles	0	VO_0006095
337	Saponin Vaccine Adjuvant	4	VO_0001267
338	SBAS2	0	VO_0005529
339	Sclavo peptide	0	VO_0001313
340	Sendai Proteoliposomes, Sendai-containing Lipid Matrices	0	VO_0001350
341	Shrimp anti-lipopolysaccharide factor	1	VO_0005270
342	SLA-AF	0	VO_0005482
343	SLA-Alum	0	VO_0006100
344	SLA-LSQ	0	VO_0005422
345	SLA-SE	0	VO_0005423
346	solid nanoemulsion	0
347	solid-in-oil-in-water emulsion	0	VO_0005756
348	sPD-1	0	VO_0005718
349	Specol	1	VO_0001314
350	spontaneous nanoliposome antigen particleization	0	VO_0005665
351	SPT (Antigen Formulation)	1	VO_0001315
352	SQ	0	VO_0005389
353	Squalene-based Adjuvants	1	VO_0000190
354	Stable Emulsion (SE) vaccine adjuvant	0	VO_0006101
355	Stearyl Tyrosine	1	VO_0001316
356	sticholysin ||	0	VO_0005636
357	SWE	0	VO_0005388
358	t-NanoCpG	0	VO_0005761
359	T-vant	0	VO_0005375
360	T7-alum	1	VO_0005270
361	Taishan Robinia Pseudoacacia polysaccharides	0
362	TDM	0	VO_0005587
363	TF-Al	0	VO_0005751
364	Theramide®	1	VO_0001317
365	Threonyl muramyl dipeptide (TMDP)	1	VO_0001351
366	TiterMax Gold Adjuvant	3	VO_0001260
367	TLR-7 andTLR-8 Agonist	0	VO_0005674
368	TLR3	0
369	TLR4 agonist lipopolysaccharides	1	VO_0005270
370	TLR5	1	VO_0005270
371	TLR7-8 RNA ligands	0	VO_0005734
372	TLRa	0	VO_0005656
373	TQL-1055	0	VO_0005283
374	TRAC478	0	VO_0005384
375	trichosanthin	0	VO_0005750
376	TRIF	0	VO_0005545
377	Tumour-derived exosomes (TEXs)	0
378	Ty Particles vaccine adjuvant	1	VO_0001352
379	U-Omp19 and alum	0	VO_0005762
380	UM-1098	0	VO_0005282
381	UM-3003	0	VO_0005354
382	UM-3004	0	VO_0005353
383	UM-3005	0	VO_0005337
384	V155M	0	VO_0005724
385	VISA	0	VO_0005556
386	VLP@Silica	0	VO_0005770
387	VSA-1	0	VO_0005326
388	VSA-2	0	VO_0005325
389	VSA-3 Adjuvant	2	VO_0001266
Total		418 (unique ones)

Vaccines with adjuvants by vaccine targeted pathogens or diseases

Pathogen or disease	No. of pathogen species	DNA vaccine	Toxoid vaccine	Subunit vaccine	Subunit vaccine + Inactivated or "killed" vaccine	Conjugate vaccine	Inactivated or "killed" vaccine	Recombinant vector vaccine	Live, attenuated vaccine	Fusion protein with adjuvant	Other	trivalent human seasonal influenza vaccine (TIV)	Prime-boost vaccine with DNA vaccine priming	Total
G- bacterium	22/51	2	6	97	11	7	2	6	0	0	0	0	0	131
G+ bacterium	11/17	2	26	39	17	6	4	1	0	1	0	0	0	96
parasite	15/25	6	0	52	0	0	1	4	1	0	0	0	2	66
Allergy	1/1	0	0	1	0	0	0	0	0	0	0	0	0	1
Cancer	1/1	7	0	13	0	1	0	8	1	0	4	0	0	34
Atherosclerosis	1/1	0	0	2	0	0	0	0	0	0	0	0	0	2
virus	28/115	2	0	44	11	0	23	1	3	0	0	1	0	85
fungus	1/1	0	0	3	0	0	0	0	0	0	0	0	0	3
Total	80/212	19	32	251	39	14	30	20	5	1	4	1	2	418

Click here for the list of vaccines that use two or more adjuvants.